Cancer Clinical Trials Program
GPTKB entity
Statements (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:hospital
|
| gptkbp:addresses |
various cancer types
|
| gptkbp:aimsTo |
improve patient outcomes
advance medical knowledge |
| gptkbp:analyzes |
clinical data
|
| gptkbp:collaboratesWith |
research institutions
|
| gptkbp:collectibility |
data on treatment efficacy
|
| gptkbp:focusesOn |
cancer treatment
|
| gptkbp:hasCollaboratedWith |
government agencies
academic institutions international organizations pharmaceutical companies |
| gptkbp:hasFacility |
medical professionals
various locations multidisciplinary teams clinical settings patient involvement clinical protocols |
| https://www.w3.org/2000/01/rdf-schema#label |
Cancer Clinical Trials Program
|
| gptkbp:includes |
phases of clinical trials
|
| gptkbp:involves |
patient recruitment
|
| gptkbp:isAvailableIn |
eligible patients
|
| gptkbp:isDesignedFor |
specific patient populations
enhance treatment options address unmet medical needs |
| gptkbp:isEnhancedBy |
technology
|
| gptkbp:isEvaluatedBy |
peer review
regulatory bodies statistical analysis clinical outcomes longitudinal studies patient-reported outcomes clinical researchers clinical endpoints |
| gptkbp:isFocusedOn |
evidence-based practices
personalized medicine innovative therapies quality of life improvements survivorship issues treatment innovation |
| gptkbp:isFundedBy |
government grants
|
| gptkbp:isInformedBy |
patient feedback
previous research |
| gptkbp:isLinkedTo |
patient registries
biomedical research health outcomes research |
| gptkbp:isPartOf |
cancer research initiatives
multicenter trials integrated care models healthcare_systems |
| gptkbp:isPortrayedBy |
medical journals
|
| gptkbp:isPromotedBy |
medical professionals
advocacy groups |
| gptkbp:isPromotedThrough |
community outreach
|
| gptkbp:isSubjectTo |
ethical guidelines
regulatory oversight |
| gptkbp:isSupportedBy |
grants
non-profit organizations research funding industry partnerships patient advocacy organizations |
| gptkbp:mayHave |
placebo-controlled trials
FDA_approval |
| gptkbp:monitors |
patient safety
|
| gptkbp:offers |
clinical trials
support services |
| gptkbp:provides |
patient education
access to experimental therapies |
| gptkbp:requires |
informed consent
|
| gptkbp:utilizes |
biomarkers
|